<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Thursday, Oct. 4, 2007</title>
	<atom:link href="http://venturebeat.com/2007/10/04/life-sciences-briefing-thursday-oct-4-2007/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/10/04/life-sciences-briefing-thursday-oct-4-2007/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Wed, 25 Nov 2009 21:25:26 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; Specialty pharma Hyperion raises $15M in debt, names execs</title>
		<link>http://venturebeat.com/2007/10/04/life-sciences-briefing-thursday-oct-4-2007/comment-page-1/#comment-562998</link>
		<dc:creator>VentureBeat &#187; Specialty pharma Hyperion raises $15M in debt, names execs</dc:creator>
		<pubDate>Thu, 04 Oct 2007 17:22:07 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/10/04/life-sciences-briefing-thursday-oct-4-2007/#comment-562998</guid>
		<description>[...] our story on this South San Francisco, Calif., specialty pharmaceutical company in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story on this South San Francisco, Calif., specialty pharmaceutical company in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; ATP Pharma raises $22M for transplant-rejection drug</title>
		<link>http://venturebeat.com/2007/10/04/life-sciences-briefing-thursday-oct-4-2007/comment-page-1/#comment-562564</link>
		<dc:creator>VentureBeat &#187; ATP Pharma raises $22M for transplant-rejection drug</dc:creator>
		<pubDate>Thu, 04 Oct 2007 14:34:00 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/10/04/life-sciences-briefing-thursday-oct-4-2007/#comment-562564</guid>
		<description>[...] our story on this Burlingame, Calif., specialty pharma in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story on this Burlingame, Calif., specialty pharma in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; ATP Pharma raises $22M for transplant-rejection drug</title>
		<link>http://venturebeat.com/2007/10/04/life-sciences-briefing-thursday-oct-4-2007/comment-page-1/#comment-562578</link>
		<dc:creator>VentureBeat &#187; ATP Pharma raises $22M for transplant-rejection drug</dc:creator>
		<pubDate>Thu, 04 Oct 2007 14:34:00 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/10/04/life-sciences-briefing-thursday-oct-4-2007/#comment-562578</guid>
		<description>[...] our story on this Burlingame, Calif., specialty pharma in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story on this Burlingame, Calif., specialty pharma in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
